Oncocyte Reports Full Year 2023 Financial Results
April 12, 2024 06:00 ET
|
OncoCyte Corporation
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
April 11, 2024 21:46 ET
|
OncoCyte Corporation
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
April 11, 2024 17:30 ET
|
OncoCyte Corporation
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
April 09, 2024 16:05 ET
|
OncoCyte Corporation
ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
RTI and GE HealthCare Take the Stage at DeviceTalks Boston 2024
April 09, 2024 08:00 ET
|
Real-Time Innovations (RTI)
RTI and GE HealthCare take the stage at DeviceTalks Boston 2024.
Reuters Publishes Pulsar Helium Film Documentary
April 05, 2024 07:38 ET
|
Pulsar Helium
Reuters Publishes Pulsar Helium Film Documentary
[Latest] Global Beauty Supplement Market Size/Share Worth USD 8.2 Billion by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 01, 2024 11:30 ET
|
Custom Market Insights
Austin, TX, USA, April 01, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Beauty Supplement Market Size, Trends and Insights By Form (Tablets, Capsules,...
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market Growth
March 27, 2024 09:00 ET
|
FN Media Group LLC
PALM BEACH, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Artificial intelligence (AI) in the healthcare market is highly competitive due to a significant number of...
Retrieve Medical Holdings, Inc. (RMHI) Announces Study Update Results Utilizing Retrieve Dx ™ Software
March 22, 2024 08:00 ET
|
Retrieve Medical, Inc.
RETRIEVE MEDICAL HOLDINGS, INC. (RMHI) ANNOUNCES STUDY UPDATE RESULTS UTILIZING RETRIEVE DxTM SOFTWARE
Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
March 20, 2024 08:00 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, March 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD)...